Kimball Electronics, Inc. (KE) Q1 2025 Earnings Call Transcript Summary
Kimball Electronics, Inc. (KE) Q1 2025 Earnings Call Transcript Summary
The following is a summary of the Kimball Electronics, Inc. (KE) Q1 2025 Earnings Call Transcript:
以下是kimball electronics,Inc. (KE) 2025財年第一季度業績會議記錄摘要:
Financial Performance:
財務業績:
Kimball Electronics reported a Q1 FY 2025 revenue of $374 million, a 15% decrease year-over-year when excluding AT&M.
Gross margin rate decreased to 6.3%, down 180 basis points from the same quarter last year, primarily due to lower sales absorption.
Adjusted operating income was $12.6 million, down from $21 million in Q1 FY 2024.
Net income was adjusted to $5.5 million, or $0.22 per diluted share.
kimball electronics報告2025財年第一季度營業收入爲37400萬美元,同比減少15%,不含AT&m。
毛利率下降至6.3%,比去年同期下降180個點子,主要是由於銷售吸收較低。
調整後的營業收入爲1260萬美元,較2024財年第一季度的2100萬美元下降。
淨利潤調整爲550萬美元,每股攤薄盈利爲0.22美元。
Business Progress:
業務進展:
Restructured by divesting non-core AT&M business and integrating medical CMO into EMS operations.
Announced the closure of the Tampa manufacturing facility to streamline operations and improve efficiency.
Focused on high-value manufacturing in medical devices and automotive, with new programs launching.
Achieved a $147 million reduction in inventory, enhancing working capital efficiency.
通過剝離非核心AT&m業務並將醫療器械CMO整合到EMS業務中進行重組。
宣佈關閉坦帕製造廠以優化運營並提高效率。
專注於醫療設備和汽車領域的高價值製造,新項目正在啓動。
庫存削減了14700萬美元,提高了營運資本效率。
Opportunities:
機會:
Strategic focus on high-level medical device assemblies and new automotive programs presents growth opportunities.
Continuing restructuring efforts anticipated to bring improved margins and profitability.
戰略聚焦於高水平醫療器械組件和新汽車項目,帶來增長機會。
持續的重組努力預計將帶來改善的毛利率和盈利能力。
Risks:
風險:
Persistent end market softness poses ongoing challenges for demand and revenue.
Closure of the Tampa facility involves risks related to transferring operations and potential disruptions.
持續的終端市場疲軟對需求和營業收入構成持續挑戰。
關閉坦帕設施涉及轉移業務和潛在的風險。
Tips: This article is generated by AI. The accuracy of the content can not be fully guaranteed. For more comprehensive details, please refer to the IR website. The article is only for investors' reference without any guidance or recommendation suggestions.
提示:本文由人工智能生成。內容準確性無法完全保證。如需更全面詳情,請參閱IR網站。本文僅供投資者參考,不具有任何指導或推薦建議。